CLINICAL_TRIALS
trial_result
· 2013-02-07
Clinical Trial Update: BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus [Phase 3]
Summary
A Phase 3 trial investigating lorcaserin for overweight/obesity in adults with diabetes (BLOOM-DM) has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2013-02-07